develop a generalized version of pulsed field ablation device
Forecast New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Points of contact
-
- CDRH Acquisition Liaison cdhracquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring research and development services to develop a generalized version of a pulsed field ablation device, with solicitation expected to release on May 1, 2027 and award targeted for September 1, 2027. The contractor will develop different electrode geometries to test the effect of electrode geometry on ablation outcome, with hemolysis assessment performed in-house by the agency.
The estimated award value ranges from $25,000 to $250,000. Inquiries should be directed to the FDA's Center for Devices and Radiological Health acquisitions mailbox at cdhracquisitions@fda.hhs.gov.
Forecast text
BPID:753 -this contract will be used to develop a generalized version of pulsed field ablation device. Contractor will develop different electrode geometries to test the effect of electrode geometry on ablation outcome. Hemolysis assessment will be done in-house
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast